Thymosin Beta-4 Full Fragment

Also known as: TB4 Full Fragment, Tβ4, Thymosin β4 (full length)

Muscle & Recovery

Phase III

Thymosin Beta-4 Full Fragment is the complete 43-amino acid form of TB-4, offering superior tissue repair, anti-inflammatory, and regenerative properties compared to the truncated TB-500 fragment.

Regulatory & Approval Status

Not FDA Approved

The full-length protein has reached Phase 3 clinical trials (e.g., for neurotrophic keratopathy), but it remains unapproved by the FDA.

Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.

Unlock the complete research profile

Create your free CertifiedTide account to access full compound details, mechanisms, safety data, and research tools.